One-Third With Inflammatory Bowel Disease Have Moderate-to-Severe Disability

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

WEDNESDAY, April 15, 2026 -- Moderate-to-severe disability affects nearly one-third of patients with inflammatory bowel disease (IBD), according to a review published online March 5 in Inflammatory Bowel Diseases.

Olga Maria Nardone, Ph.D., from University of Naples Federico II in Italy, and colleagues conducted a systematic literature review to assess the pooled prevalence of moderate-to-severe disability and investigate how IBD type, disease activity, geographic location, and questionnaire used influenced prevalence.

Based on 17 articles (7,897 patients in 17 countries), the researchers found that the pooled prevalence of moderate-to-severe disability in patients with IBD was 29.6 percent and was higher in patients with active IBD (56.9 percent) versus those with inactive disease (27.0 percent). Disease activity more than tripled the odds of moderate-to-severe disability in three studies (odds ratio, 3.13). Moderate-to-severe disability was higher in patients with Crohn disease (36.9 percent) versus those with ulcerative colitis (30.8 percent; odds ratio, 1.26).

"This systematic review is the first, to our knowledge, to show that moderate-to-severe disability affects nearly one-third of patients with IBD, with higher rates in Crohn disease and active disease," the authors write. "Importantly, disability persists in a substantial proportion of patients even during remission, supporting the need for systematic assessment across clinical settings."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-16 09:13

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords